看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。 D( I" F" G2 F1 G7 G* _8 b
7 q y* V- {8 e0 u
. F! p7 u5 W) G# D' g
Currently available feasibility data for possible combination strategies.
# Q; k! J. M" p! c; n————————————————————————————————
* h% h2 T" @+ M# p/ ^- W qCombination Feasibility according to preliminary data ' G* E, }, l2 M! y
——————————————————————————————————
( Z& |2 u# j, A5 w; P2 Z6 x( _% A1 QBevacizumab + sorafenib Yes, reduced dose
0 K# N8 C( A' v( b9 L% kBevacizumab + sunitinib† No $ P& H! s v! x7 ?
Bevacizumab + temsirolimus Yes
6 T/ b: }" T$ C& O' g" `Bevacizumab + everolimus Yes ) f( N* `2 [& Z& g8 y% N
Sorafenib + sunitinib ? - a9 p! z2 v; J# e# r" F
Sorafenib + temsirolimus Yes, reduced dose
0 r4 M* K' V9 }& ~* H; Y( LSorafenib + everolimus Yes, reduced dose
/ f/ B W8 K/ U0 `8 K4 gSunitinib + temsirolimus† No
4 J1 B' G) \7 OSunitinib + everolimus ?
' U6 C4 W& a+ V5 D2 KTemsirolimus + everolimus ?
; T/ u( r0 q4 ^: ^' y$ N————————————————————9 S! F& O, D2 m# v) J& r
†Led to US FDA warning., C6 o$ }6 W' ?2 f; {- p
?: As yet unattempted combination.
: W7 y1 k% l) P9 A" m$ r |